7-(1,3-dimethyl-1H-pyrazol-5-yl)-3-(3-((4-methyl-5-(2-methyl-5-quinolinyl)-4H-1,2,4-triazol-3-yl)thio)propyl)-2,3,4,5-tetrahydro-1H-3-benzazepine

InChIKey	`WIHMMKGUBDZGEG-UHFFFAOYSA-N`
Compound Name	7-(1,3-dimethyl-1H-pyrazol-5-yl)-3-(3-((4-methyl-5-(2-methyl-5-quinolinyl)-4H-1,2,4-triazol-3-yl)thio)propyl)-2,3,4,5-tetrahydro-1H-3-benzazepine
Canonical SMILES	`Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	7
Pfam Stratification	Homologous
Avg pChEMBL	6.8
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P35462	DRD3	Homo sapiens	Human	PF00001	8.8	Ki	ChEMBL;BindingDB
P08173	CHRM4	Homo sapiens	Human	PF00001	6.8	IC50	ChEMBL
P28221	HTR1D	Homo sapiens	Human	PF00001	6.7	Ki	ChEMBL
P08172	CHRM2	Homo sapiens	Human	PF00001	6.5	IC50	ChEMBL
P14416	DRD2	Homo sapiens	Human	PF00001	6.5	Ki	ChEMBL;BindingDB
P08912	CHRM5	Homo sapiens	Human	PF00001	6.2	IC50	ChEMBL
P35367	HRH1	Homo sapiens	Human	PF00001	6.1	Ki	ChEMBL